Diagnosis and treatment of syphilis are challenging because of the condition's diverse clinical symptoms, histopathological variance, and the lack of definite tests for treatment follow-up. We report a case of secondary pustular-ulcerative malignant syphilis with ocular involvement in a human immunodeficiency virus-infected patient. It was striking to find that ulcerative lesions can be highly organism depleted.
patient's condition remained stable up to the last follow-up serologic test 5 months before the onset of the aforementioned symptoms.
Because of the pustular character of the lesions, prior to the patient's presentation at our clinic, the patient received ciprofloxacin for suspected impetigo, brivudine for herpes zoster, topical ciclopirox for possible tinea, and topical nadifloxacin. Because no therapeutic response occurred, a skin biopsy specimen was obtained. The histopathologic diagnosis suggested an infectious pathogenesis. Because additional diagnostic tests for spirochetes, Bartonella species, mycobacteria, and fungal species yielded negative results, no specific treatment was initiated. When he experienced progressive skin involvement and ocular changes, the patient was referred to our clinic for further evaluation.
Physical examination findings were notable for large, confluent papules and pustules and plaques on the right temple, nose, scalp, and left arm. Many lesions demonstrated central, crusted ulcerations (figure 1A, 1B, and 1D). The patient's oral and genital mucosa, palms, and soles were free of lesions.
Ocular examination revealed conjunctival vascular injections with subconjunctival hemorrhage, keratitis, and a scleral nodule of the left eye (figure 1C). Moderate lymphadenopathy was present. Findings of additional examination were unremarkable.
Laboratory diagnostic evaluation was notable for an elevated C-reactive protein level Histologic examination of a newly obtained skin biopsy specimen demonstrated a deep, confluent, nodular cellular infiltrate with lymphocytes, histiocytes, and an abundance of plasma cells. There was notable vacuolization of the basal layer with necrotic keratinocytes, lymphocytes, and plasma cells ( figure  2D ). The presence of treponemes, however, could be demonstrated by neither immunohistochemical staining nor DNA PCR (followed by PCR-ELISA).
Because of the rapid increase in the VDRL titer and the elevated TPPA titers in this patient, who had stable immunological status (and a history of sexual contacts during the prior 6 months with different men who have sex with men who had a higher risk of carrying or transmitting syphilis), we diagnosed syphilis reinfection. Secondary syphilis infection plus systemic symptoms, arthralgias, elevated liver enzyme levels, and pustular-ulcerative lesions was classified as malignant syphilis.
The patient received 3 consecutive weekly intramuscular injections of benzathine penicillin (2.4 million IU). The patient also received a 50-mg dose of prednisolone concurrently with the first dose of benzathine penicillin, to prevent a Herxheimer reaction. While receiving therapy, the skin and eye conditions rapidly resolved (figure 2). A VDRL test performed 3 months after completion of therapy revealed a 4-fold reduction of the titer (1:128), indicating a sufficient treatment outcome. The gglutamyl transpeptidase, alkaline phosphatase, and C-reactive protein levels returned to normal.
Discussion. The clinical manifestations of secondary syphilis vary greatly. Eruptions are often generalized, but localized lesions can occur. In HIV-infected patients, the course of syphilis can be atypical. Primary chancres often stay unrecognized because of their asymptomatic character and frequently hidden (anal, rectal, or enoral) location. Progression from stage to stage can be more rapid, leading to earlier symptoms of secondary or even tertiary syphilis [1] . Secondary syphilis can be classified on the basis of lesions as macular, papular, follicular, papulo-sqammous, corymbiform, frambesiform, or pustular syphilis. Pustular syphilis can be further divided into small pustular syphilide, large pustular syphilide, flat pustular syphiloderm, and pustular-ulcerative syphilide (i.e., malignant syphilis) [2, 3] . Pustular lesions occur in only 2%-4% of patients with secondary syphilis, and malignant syphilis is rare, more commonly affecting individuals with poor health, malnutrition, or HIV infection [4, 5] . Ocular syphilis also is an uncommon manifestation of the disease. Scleritis in secondary syphilis and uveitis in tertiary syphilis are reported to be the most common presentations, but keratitis and conjunctivitis can occur [6] [7] [8] .
To our knowledge, this is the first case of concomitant ocular involvement in a patient with malignant syphilis.
Neisser [9] defined the characteristics of malignant syphilis in 1897. There is a short incubation period: disease onset is characterized by prodrome (arthralgia and malaise) and skin lesions start as papules and evolve into pustules, followed by necrosis of the lesion center. High titers in serologic tests for syphilis are typical of malignant syphilis [10] . Even though it's referred to as "malignant," malignant syphilis usually responds very rapidly to proper treatment. Because secondary syphilis is a systemic disease, malaise, subclinical hepatitis (i.e., elevated liver enzyme level), and elevated alkaline phosphatase level have been reported [11] .
There have been only a few reports on the density of treponemes in skin lesions in patients with malignant syphilis. Considering the abundance of inflammatory cells in the affected skin and the elevated frequency of malignant syphilis among immunocompromised individuals, one would expect high levels of spirochetes in lesions. In our patient, however, the lesions associated with malignant syphilis revealed an extreme paucity of treponemes. Neither immunohistologic methods nor PCR demonstrated the presence of spirochetes. These methods have improved over recent years, and the diagnostic yield for the detection of treponemes or treponemal DNA is 190% for secondary syphilitic lesions [12] . None of the therapies that the patient had received should have affected these results, because the only antibiotics given were quinolones, which have been shown in different experiments to have no impact on Treponema pallidum [13] ; these treatments also did not stop the progressive clinical course of infection in our patient. Our findings are supported by those of Wile et al. [14] , who reported the presence of spirochetes in patients with malignant syphilis in different organs, including presence in accompanying maculopapular lesions of the skin, but not in the ulcerative lesions. Bahmer and Anton-Lamprecht [15] also reported highly organism-depleted lesions, and Fischer et al. [10] could not find spirochetes at all in patients with malignant syphilis.
It is still unclear why malignant syphilis is more prevalent among HIV-infected patients, because individuals with very low CD4 counts and patients with good immunologic reconstitution are both affected. Malignant syphilis also occurs in HIVuninfected individuals. Both cellular-mediated immunity and humoral immunity seem to be involved in the pathogenesis of malignant syphilis, and a functional defect (rather than a quantitative one) may be responsible [11] .
It has to be recognized that lesions due to malignant syphilis can be highly organism depleted, and treponemes cannot be detected in all secondary syphilitic lesions. Diagnosis, therefore, has to rely on a combination of clinical symptoms, serologic data, histologic data, and the findings of molecular and immunohistologic evaluations. HIV coinfection adds more diversity to the clinical pathology, and syphilis continues to be a diagnostic challenge in HIV-infected patients. Because of the resurgence of syphilis in recent years, it is important to recognize that uncommon lesions that one suspects to have been caused by infectious agents could be syphilitic, and early diagnosis (by serum testing) should be sought.
